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Summary
 
T cell hybridomas isolated from nonresponder H-2
 
b
 
 mice immunized with pork insulin were
stimulated by insulin in the presence of major histocompatibility complex (MHC)-unmatched
antigen presenting cells. The restriction element used by these CD4
 
2
 
 T cells was mapped to an
oligomorphic MHC class Ib protein encoded in the T region and identified as Qa-1
 
b
 
 using
transfectants. The antigenic determinant was localized to the insulin B chain, and experiments
with truncated peptides suggested that it is unexpectedly long, comprising most or all of the 30
amino acid B chain. The antigen processing pathway used to present insulin to the Qa-1
 
b
 
–
restricted T cells does not require transporters associated with antigen processing (TAP), and it
is inhibited by chloroquine. A wide variety of cell lines from different tissues efficiently present
soluble insulin to Qa-1
 
b
 
–restricted T cells, and insulin presentation is not enhanced by phago-
cytic stimuli. Our results demonstrate that Qa-1
 
b
 
 can function to present exogenous protein to
T cells in a manner similar to MHC class II molecules. Therefore, this class Ib protein may
have access to a novel antigen processing pathway that is not available to class Ia molecules.
Key words: antigen processing • major histocompatibility proteins • class Ib molecules • T 
cells • insulin
 
T
 
he family of MHC class I–related molecules in mice
includes the “classical” (class Ia) proteins H-2K, D,
and L, “nonclassical” (class Ib) molecules encoded in the
Q, T, and M regions, and 
 
b
 
2
 
-microglobulin (
 
b
 
2
 
m)
 
1
 
-associ-
ated molecules such as CD1 that are encoded by genes not
linked to the MHC (1–3). In most species, the class Ib
genes significantly outnumber the class Ia genes but the
proportion of class Ib pseudogenes is relatively high. Com-
pared with class Ia genes, class Ib genes are relatively non-
polymorphic, with few alleles and relatively small differ-
ences between alleles. The tissue distribution of class Ib
gene products is heterogeneous, and expression levels are
generally lower than those observed for class Ia proteins.
Although the function of class Ib molecules remains un-
known, it is likely that different molecules may have differ-
ent functions, and there is a growing body of evidence that
certain nonclassical class I proteins have specialized antigen
presentation function. For example, H-2M3 has a special-
ized capacity to present 
 
N
 
-formylated peptides which, re-
gardless of sequence, bind poorly to class Ia molecules (4).
This protein may have evolved to play a special role in the
immune response to bacteria (5). Human CD1b is selec-
tively targeted to endosomal compartments (6), where it
can bind and present bacterial lipid antigens to TCR 
 
a
 
/
 
b
 
T cells (7, 8).
The T region–encoded Qa-1 molecule, first identified
serologically (9), has long been considered as a transplanta-
tion antigen that can be recognized by alloreactive CTLs
(10–13). Qa-1 is expressed in tissues with a distribution
similar to class Ia proteins but cell-surface density is rela-
tively low. Four Qa-1 alleles have been characterized by
serological and CTL assays, and the genes encoding two of
these, Qa-1
 
b
 
 (14, 15) and Qa-1
 
a
 
 (16), have been cloned. A
large fraction of Qa-1
 
b
 
–reactive TCR 
 
a
 
/
 
b
 
 CTLs have
been shown to recognize a nonameric peptide, Qdm (Qa-1
determinant modifier), derived from the signal sequence of
 
1
 
Abbreviations used in this paper:
 
 
 
b
 
2
 
m, 
 
b
 
2
 
-microglobulin; BFA, brefeldin A;
ER, endoplasmic reticulum; Ii, class II invariant chain; IR, insulin recep-
tor; Qdm, Qa-1 determinant modifier; SEB, staphylococcal enterotoxin
B; TAP, transporters associated with antigen processing.
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class Ia H-2D and L molecules (17, 18). Peptide extraction
studies suggest that the peptides bound to Qa-1
 
b
 
 molecules
in activated T cells and transfected cells have limited hetero-
geneity, and that Qdm is the dominant peptide associated
with this protein (18–20). Additional studies suggest that
other antigens may also be presented by Qa-1
 
b
 
. Vidovic et al.
(21) reported the isolation of a Qa-1
 
b
 
–restricted TCR 
 
g
 
/
 
d
 
T cell hybridoma that recognizes the amino acid polymer
poly(Glu
 
50
 
Tyr
 
50
 
). Imani and Soloski (22) demonstrated that
cell surface Qa-1
 
b
 
 expression is selectively upregulated after
heat shock. A tryptic digest of 
 
Mycobacterium bovis
 
 65-kD
heat shock protein was observed to stabilize cell surface
Qa-1
 
b
 
 molecules, suggesting that this protein may be in-
volved in presenting heat shock protein–derived peptides
to the immune system. Jiang et al. (23) reported that Qa-
1
 
b
 
–restricted CTLs are involved in peripheral deletion of
TCR V
 
b
 
8
 
1
 
 CD4
 
1
 
 T cells after injection with staphylococ-
cal enterotoxin B (SEB) superantigen. These CTLs killed
TCR V
 
b
 
8
 
1
 
 but not V
 
b
 
8
 
2
 
 T cells, suggesting that they
recognize an endogenous TCR V
 
b
 
-derived peptide(s) pre-
sented by Qa-1 (23). Bouwer et al. (24) demonstrated re-
cently that Qa-1
 
b
 
–restricted CTLs are induced after infec-
tion with the intracellular pathogen, 
 
Listeria monocytogenes
 
.
These CTLs specifically lyse Qa-1
 
b
 
–expressing, 
 
L
 
.
 
 monocy-
togenes
 
–infected cell lines, indicating that they directly rec-
ognize a bacterial antigen presented by Qa-1. Thus, it is
clear that Qa-1 can function as an antigen-presenting mol-
ecule in a variety of situations, but generalizations concern-
ing its role in the immune system are difficult to make.
In this study, we describe T cell hybridomas isolated
from nonresponder H-2
 
b
 
 mice immunized with pork insu-
lin that recognize an insulin B chain determinant presented
by Qa-1
 
b
 
. The antigen processing pathway used to present
insulin to these T cells appears to be distinct from the un-
conventional pathway(s) described previously for the pre-
sentation of exogenous protein antigens to MHC class Ia–
restricted T cells.
 
Materials and Methods
 
Protein and Peptide Antigens.
 
Beef and pork insulin were pur-
chased from Elanco Animal Health (Indianapolis, IN). The desocta-
peptide of beef insulin and sulfonated B chain were generated as
described previously (25). Sperm whale myoglobin was purchased
from Sigma Chemical Co. (St. Louis, MO). Peptides were synthe-
sized using a peptide synthesizer (model 430A; Applied Biosystems
Inc., Foster City, CA) in the Emory University Microchemical
Facility or by using F-MOC chemistry with a Symphony multiple
peptide synthesizer (Rainin Instrument Co., Inc., Woburn, MA).
 
Mice.
 
Female C57BL/10SnJ (B10), C57BL/6J (B6), B10.
BR/SgSnJ, C3H/HeJ, BALB/cByJ, A/J, A.BY/SnJ, and SJL/J
were purchased from The Jackson Laboratory (Bar Harbor, ME).
MHC class II–negative, C2D (A
 
b
 
2
 
/
 
2
 
) mice were purchased from
GenPharm International (Mountain View, CA). C57BL/6J-
 
b
 
2m
 
tm1Unc
 
 (
 
b
 
2
 
m
 
2
 
/
 
2
 
) breeder pairs were purchased from The Jack-
son Laboratory, and maintained by the Emory University Animal
Facilities in specific pathogen–free conditions. H-2M–deficient,
B6,129-
 
H2-Ma
 
tm1Luc
 
 (H2-Ma
 
2
 
/
 
2
 
) mice (26) and C57BL/6J-
 
Tap1
 
tm1Arp
 
 (Tap1
 
2
 
/
 
2
 
) mice (27) were the gift of Dr. Luc van Kaer
(Vanderbilt University, Nashville, TN). Spleen cells from class II
invariant chain (Ii) knockout mice (28) were provided by Dr. Al-
exander Y. Rudensky (University of Washington, Seattle, WA).
B6-Tla
 
a
 
 and A-Tla
 
b
 
 mice were maintained under pathogen-free
conditions at Johns Hopkins School of Medicine. Mice were used
at 8–11 wk of age.
 
Cells and Cell Lines.
 
The Qa-1
 
b
 
–expressing L cell transfec-
tant, L-g37, and vector control, L-V, were generated as described
(22). TH2.2 (29) and LB 27.4 (30) are H-2
 
b
 
3
 
d
 
 B hybridomas,
whereas A20 is a BALB/c-derived B lymphoma (31) and
EL4.CW (32) is an H-2
 
b
 
 T cell lymphoma. The P815 DBA/2–
derived mastocytoma (TIB-64) was obtained from the American
Type Culture Collection (Rockville, MD). BW1100-129.237
(33) is a TCR 
 
a
 
/
 
b
 
2
 
/
 
2
 
 derivative of BW5147. The C3H-derived
melanoma, K1735-M2 (34), was a gift of Dr. I. Fidler (M.D.
Anderson Cancer Center, Houston, TX), and the F10Q clone of
B16 melanoma was obtained from Dr. C. Armstrong (Emory
University, Atlanta, GA). Dr. D. Accili (National Institutes of
Health, Bethesda, MD) provided transformed hepatocyte cell
lines generated from insulin receptor-deficient (IR
 
2
 
/
 
2
 
) and IR
 
1
 
/
 
1
 
littermates (35). B3Z, a CD8
 
1
 
 T-T hybridoma specific for OVA
257-264 (SIINFEKL) presented by K
 
b
 
, was provided by Dr. N.
Shastri (University of California, Berkeley, CA). Insulin-specific
T cell hybridomas (25) were prepared from C57BL/10SnJ mice
immunized subcutaneously with 50 
 
m
 
g pork insulin emulsified in
CFA. 9–12 d after immunization, lymphocytes were isolated
from draining lymph nodes and cultured for 4 d at 10
 
7
 
 cells/ml
with 100–200 
 
m
 
g/ml pork insulin in RPMI 1640 supplemented
with 0.5% freshly prepared normal mouse serum, 2 mM glu-
tamine, 50 
 
m
 
M 2-ME, 10 
 
m
 
g/ml gentamicin, 1 mM sodium
pyruvate, 50 U/ml penicillin, and 50 
 
m
 
g/ml streptomycin. Viable
lymphocytes isolated on a Ficoll gradient were fused at a ratio of
1:2 or 1:3 with T lymphoma cells and selected in RPMI 1640
supplemented with 20% FCS and 2 mM HAT. T cell hybrids
were produced using BW5147 (Pb13, Pb1.4) or 3B2-E7 (6C5,
B1A4), a CD8-transfected, TCR 
 
a
 
/
 
b
 
2
 
/
 
2
 
 derivative of BW5147
(36) provided by Dr. P. Gottlieb. Hybrids were expanded in me-
dium containing hypoxanthine and thymidine for initial screen-
ing. Primary wells containing cells secreting lymphokine after
stimulation with pork insulin in the presence of C57BL/10SnJ
splenocytes as APCs were subcloned by limiting dilution. Pheno-
types were determined by using indirect immunofluorescence
and flow cytometry. All hybridomas express TCR 
 
a
 
/
 
b
 
 but not
TCR 
 
g
 
/
 
d
 
. Pb13 (CD4
 
2
 
CD8
 
2
 
), 6C5 (CD4
 
2
 
CD8
 
1
 
), Pb1.4
(CD4
 
1
 
CD8
 
2
 
), and B1A4 (CD4
 
1
 
CD8
 
1
 
) are representative of hy-
bridomas isolated from multiple independent fusions.
 
Cos Cell Transfection.
 
Transiently transfected Cos cells ex-
pressing Qa-1
 
b
 
 were generated using Qa-1b cDNA cloned into
the mammalian expression vector pCDNA3.0 (Invitrogen Corp.,
Carlsbad, CA). On day 0, 3.0 3 105 Cos (37) cells were plated in
5 ml supplemented DMEM/10% FCS, in 6 cm tissue culture
dishes. Cultures were aspirated on day 1 and washed twice with
DMEM plus 10 mM Hepes. To each dish, 2 ml DMEM plus 10
mM Hepes was added, containing 1 mg sterile cDNA (or vector
only), 500 mg DEAE-dextran, and 20 ml 10 mM chloroquine.
Petri dishes were incubated for 3 h at 378C, 7% CO2. After incu-
bation, plates were aspirated, and 2 ml of 10% DMSO in DMEM
plus 10 mM Hepes was added. Petri dishes were incubated 1–2
min, aspirated, and 5 ml DMEM/10% FBS was added. Plates
were incubated for 24–48 h before cell removal by trypsinization
and use in T cell assays. Qa-1b expression was measured using in-
direct immunofluorescence and flow cytometry with a Qa-1b–
specific rabbit antiserum.963 Tompkins et al.
Analysis of Qa-1 Expression by Flow Cytometry. Rabbit antisera
were generated with a synthetic peptide from the a2 domain of
Qa-1b, and the IgG fraction was purified using protein A–Seph-
arose affinity chromatography. Cells (106) were incubated with
Qa-1b–specific or control rabbit IgG (10–20 mg/ml) in 50 ml PBS
containing 1% FCS for 30–45 min, washed, and further incu-
bated with FITC-labeled goat anti–rabbit IgG (Southern Bio-
technology Associates, Inc., Birmingham, AL). Fluorescence was
analyzed using a FACScanÒ (Becton Dickinson, San Jose, CA).
Culture Conditions and Lymphokine Assay. Cultures were per-
formed in 96-well tissue culture plates in a final volume of 200
ml/well of RPMI 1640 supplemented with 10% FCS plus addi-
tives as described above. T cell hybridomas (5 3 104 or 105/well)
were cultured for 24 h in the presence of various antigens and
APCs. In experiments with inhibitors, APCs were pretreated
with inhibitor for 1 h followed by the addition of antigen fol-
lowed by an additional 4 h of culture. APCs were washed and
fixed by exposure to 0.5% paraformaldehyde for 10 min at 248C,
followed by three washes in serum-containing medium. Thiogly-
collate-induced peritoneal exudate cells were obtained through
lavage of the peritoneal cavity of mice injected intraperitoneally
3–5 d previously with 2 ml thioglycollate broth. Peritoneal cells
(5 3 104/well) were cultured for 1.5 h at 378C to allow mac-
rophages to adhere, and nonadherent cells were removed by
washing before T cell addition. In some experiments, 4.5 mm
goat anti–rabbit DynabeadsÔ (Dynal, A.S., Oslo, Norway) were
added to stimulate phagocytosis (38). Lymphokine production,
reflecting T cell activation, was quantified by measuring prolifera-
tion of the IL-2–dependent T cell line, CTL-L. Culture superna-
tants (100 ml) were transferred to flat-bottomed, 96-well tissue
culture plates, freeze–thawed once, and cultured with 104 CTL-L
cells/well for 24 h. Each well was pulsed with 1 mCi of [3H]thy-
midine during the final 18 h of culture. All experiments were
performed in triplicate, and data are representative of at least two
independent experiments.
Results
In multiple independent fusions, we have isolated T cell
hybridomas from pork insulin–primed nonresponder H-2b
mice that specifically recognize insulin but appear to be
MHC-unrestricted based on the observation that they can
be stimulated in the presence of MHC-mismatched APCs.
These hybridomas express a/b TCRs, and CD8 is ex-
pressed only if a CD81 fusion partner is used to generate
the cell lines. They do not express CD4 or g/d TCRs (data
not shown). The T cells might recognize insulin peptides
presented by nonpolymorphic MHC proteins, peptides
bound to an alternative site in MHC class II molecules, or
they may be stimulated through a mechanism completely
independent of MHC molecules. The possibility that insu-
lin may directly stimulate the T cells through hormonal re-
ceptors or other means was excluded because insulin does
not activate the T cells in the absence of accessory cells (see
below). We reported previously that insulin B chain pep-
tides can bind to an alternative site overlapping the SEB-
binding site outside of the peptide-binding groove in mul-
tiple different class II proteins (39). Therefore, the potential
requirement for MHC class II molecules was addressed by
evaluating the capacity of spleen cells from class II–defi-
cient mice to present insulin to representative T cell hybri-
domas. As expected, these cells are unable to present insu-
lin to control, IAb-restricted T cells (Fig. 1 A). In contrast,
the antigen presentation activity of class II–negative spleen
cells was equal to that of wild-type B6 cells in experiments
with MHC-unrestricted T cells (Fig. 1 B). The potential
role of MHC class I molecules was investigated using
spleen cells from b2m knockout mice, which were ob-
served to present insulin to the IAb-restricted but not the
unrestricted T cells (Fig. 1, C and D). These results sug-
gested that the unrestricted T cells recognize insulin pep-
tides presented by a nonpolymorphic b2m-dependent class
I or class I–like molecule.
The family of b2m-associated class I–related molecules
includes the classical class Ia proteins K, D, and L, class Ib
proteins encoded in the Q, T, and M regions of the MHC,
and molecules such as CD1 that are not encoded in the
MHC. Experiments with APCs from a panel of inbred
mice demonstrated a correlation between the identity of al-
leles encoded in the T region with the capacity to present
insulin to Pb13 and 6C5 T cell hybridomas (Fig. 2). Anti-
gen presentation did not correlate with class Ia loci or the
Q or M regions. The restriction element was definitively
mapped using congenic strains differing only in the T re-
gion. APCs from A/J-Tlab and B6-Tlab (Tb) mice pre-
sented insulin to 6C5 T cells, whereas those from congenic
Ta strains did not (Fig. 2 B). B6-Tlaa spleen cells were fully
capable of presenting insulin to control IAb-restricted B1A4
T cells, ruling out any intrinsic defect in the general capac-
ity to present insulin to T cells.
Figure 1. MHC class I– and class II–dependent recognition of insulin.
T cell hybridomas (A) Pb1.4, (B) Pb13, (C) B1A4, and (D) 6C5 (105/
well) were cultured with 106 spleen cells in the presence (black bars) or ab-
sence (white bars) of 30 mM pork insulin. Splenic APCs were obtained
from b2m-deficient, MHC class II–deficient, or wild-type B6 mice. Re-
sults represent lymphokine production measured as described in Materials
and Methods. Pb1.4 and B1A4 are representative of MHC class II–
restricted T cells, whereas Pb13 and 6C5 are representative of b2m-
dependent T cells isolated from pork insulin–primed B10 mice.964 Insulin Recognition by Qa-1b–restricted T Cells
The T region includes at least five genes with open read-
ing frames that are transcribed or encode cell surface pro-
teins (2). TCR g/d T cell lines can recognize the T22b
gene product (40, 41). Products of the related T3/T18
genes can be recognized by TCR a/b cytotoxic T cells
and act as transplantation antigens when expressed as trans-
genes under the control of the H-2Kb promoter (42, 43).
The T23 gene (formerly known as gene 37) encodes Qa-1,
which can be recognized by alloreactive TCR a/b CTLs
(10–13, 17, 18). Recent work also demonstrates that Qa-1b
can present antigen(s) from the intracellular pathogen L.
monocytogenes to a/b CTLs (24). We used transfected cell
lines to investigate the possibility that Qa-1b was the re-
striction element recognized by our b2m-dependent, insu-
lin-specific T cells. The Qa-1b–expressing L cell transfec-
tant, L-g37, but not control transfectants, presented insulin
to 6C5 T cells (Fig. 3 A). L-g37 did not present insulin to
control, IAb-restricted B1A4 T cells. The role of Qa-1b was
confirmed using transient Cos cell transfectants (Fig. 3 B),
which ruled out the possibility that we had inadvertently
selected cells expressing Qa-1–unrelated molecules re-
quired for stimulation of 6C5 T cells during isolation of the
cloned, stably transfected L-g37 cell line. We conclude that
the unrestricted T cell hybridomas isolated from pork insu-
lin–primed H-2b mice actually recognize insulin presented
by the oligomorphic class Ib protein, Qa-1b.
The determinant specificity of pork insulin–induced
IAb- and Qa-1b–restricted T cells was investigated (Fig. 4,
and data not shown). Insulin contains a 30 amino acid B
chain peptide that is linked through two disulfide bonds to
a 21 amino acid A chain. The IAb-restricted T cells were
found to recognize a determinant within residues 17–30 of
the B chain. The Qa-1b–restricted T cells fully cross-react
with beef insulin, which differs from pork insulin by two
residues in the A chain loop that is formed by a disulfide
bond between cysteines A6 and A11. The conclusion that
the COOH terminus of the B chain is a critical component
of the determinant was suggested by the observation that
the T cells do not respond to desoctapeptide insulin, a tryp-
tic peptide missing the COOH-terminal eight amino acids
of the B chain. The antigenicity of sulfonated B chain and a
synthetic B(1-30) peptide demonstrated that the determi-
nant is fully localized in the B chain. The chemical status of
the cysteine side chains does not appear to be important,
because performic acid–oxidized insulin is antigenic. The
B1 a amino group and the B29 e amino group are not es-
sential, since biotin-N-hydroxysuccinimide derivatives re-
Figure 2. The restriction element recognized by b2m-dependent T
cells maps to the T region. (A) Pb1.4 or Pb13 T cells (5 3 104/well) were
incubated with 106 spleen cells from the indicated donor mice in the pres-
ence (black bars) or absence (white bars) of 38 mM pork insulin. (B) 6C5 or
B1A4 T cells (5 3 104/well) were incubated with 106 spleen cells from
the indicated donor mice in the presence (black bars) or absence (white bars)
of 38 mM pork insulin. Results represent lymphokine production mea-
sured as described in Materials and Methods.
Figure 3. The restriction element recognized by b2m-dependent T
cells is Qa-1b. (A) T cell hybridomas (105) were cultured with 105 TH2.2
B cells, Qa-1b–expressing (L-g37) L cell transfectants, or vector control
(LV) transfectants in the presence of 30 mM myoglobin (HMb4.2) or
pork insulin (6C5 and B1A4). (B) Cos cells were transiently transfected
with pCDNA3.0 alone (vector) or pCDNA3.0 containing cDNA encod-
ing Qa-1b. After 24 h, transfected cells (104) were cultured with 6C5 T
cells (5 3 104) in the presence (black bars) or absence (white bars) of 30 mM
pork insulin. Results represent lymphokine production measured as de-
scribed in Materials and Methods.965 Tompkins et al.
tain activity. By contrast, IAb-restricted B1A4 cells do not
respond to biotin-insulin, suggesting that the B29 Lys is a
critical component of this determinant.
The only previously characterized peptide determinant
recognized by Qa-1–restricted T cells is derived from the
leader sequence of MHC class Ia D or L molecules (18).
The Qdm nonamer (AMAPRTLLL) optimally stimulates a
large fraction of Qa-1b–restricted alloreactive CTLs. Pep-
tide binding experiments with substituted Qdm analogues
suggest that P2 and P9 may be dominant anchor positions
(44). These findings support the assumption that the pep-
tide specificity of Qa-1 is similar to class Ia proteins, with
preference for nonamers bearing appropriate residues at key
anchor positions. Given this assumption, we were surprised
to find that none of a set of overlapping nonameric pep-
tides from the COOH terminus of the pork insulin B chain
stimulated Qa-1b–restricted T cells (Fig. 4). We considered
the possibility that the T cells preferentially recognize
longer peptides. Aldrich et al. (18) reported that 10- and
11-mer Qdm derivatives extended at the COOH terminus
stimulate alloreactived CTLs almost as well as the nonamer.
However, none of a set of NH2-terminally truncated B
chain peptides beginning with B(6-30) stimulate our Qa-
1b–restricted T cells (Fig. 4). Thus, it appears that the de-
terminant recognized by these cells includes much if not all
of the full 30 amino acid B chain.
Given the near ubiquitous expression of the insulin hor-
monal receptor, it was important to rule out the possibility
that the T cells recognize a determinant unrelated to insulin
that is induced through the hormonal activity of insulin.
This possibility was unlikely, because isolated insulin B
chain has no hormonal activity (45) while retaining a ca-
pacity to stimulate the T cells. To further address this issue,
we evaluated the antigen presentation activity of a hepato-
cyte cell line derived from IR-deficient mice generated by
targeted gene disruption (35). The antigen presentation ac-
tivity of IR-negative cells was equal to that of an IR-posi-
tive control hepatocyte cell line (Fig. 5). We conclude that
the T cells directly recognize an insulin B chain determi-
nant presented by Qa-1b.
The capacity of Qa-1b class I molecules to present exog-
enous insulin suggests an unconventional antigen process-
ing pathway. Several studies have demonstrated that sub-
populations of macrophages (46–48) and dendritic cells
(49–51) have the capacity to present peptides derived from
internalized exogenous proteins via MHC class I molecules
(52, 53). In some situations, internalized proteins somehow
gain access to the cytoplasm and are processed by compo-
nents of the conventional class I pathway (38, 48, 54, 55).
In other situations, noncytosolic mechanisms are responsi-
ble for presentation of exogenous antigen by class I mole-
cules (55–57). The role of the cytosolic MHC class I path-
way in presenting insulin to Qa-1b–restricted T cells was
investigated using APCs from transporters associated with
antigen processing (TAP)-deficient mice. TAP-deficient
macrophages were observed to present insulin to Qa-1b–
restricted T cells almost as efficiently as control macrophages
(Fig. 6 A). Similar results were obtained with unfraction-
ated splenic APCs. The conclusion that Qa-1b uses a non-
cytosolic pathway for presentation of insulin was further
supported by the observation that chloroquine completely
inhibits antigen presentation (Fig. 6 B). Brefeldin A (BFA)
also inhibits presentation, probably by depleting the post-
endoplasmic reticulum (ER) pool of Qa-1b molecules. The
cellular turnover rate of Qa-1b has been reported to be
greater than that of class Ia molecules (15). The cysteine
protease inhibitor, leupeptin, did not inhibit presentation.
Leupeptin inhibits the class II antigen presentation pathway
primarily by inhibiting the proteolytic release of invariant
chain from MHC class II molecules. It is noteworthy that
the response of Qa-1b–restricted, insulin-specific T cells to
antigen-pulsed APCs is always substantially lower than that
observed when antigen is present continuously in the T cell
culture. It is possible that B chain–Qa-1b complexes are
short-lived and rapidly depleted after antigen removal.
Invariant chain has been shown to associate with a frac-
tion of MHC class I molecules, targeting them to endo-
Figure 4. Insulin B chain
specificity of IAb- and Qa-1b–re-
stricted T cells. T cells (105/well)
were incubated with 105 TH2.2
cells (B1A4) or 106 B10 spleen
cells (6C5) and 30 mM of the in-
dicated antigen. Results repre-
sent lymphokine production
measured as described in Materi-
als and Methods.
Figure 5. Antigen presenta-
tion by IR2/2 APCs. 6C5 T
cells (5 3 104/well) were cul-
tured with hepatocyte cell lines,
generated from IR2/2 and IR1/1
littermates, in the absence (black
bars) or presence of 20 mM beef
insulin (striped bars). Results rep-
resent lymphokine production
measured as described in Materi-
als and Methods.966 Insulin Recognition by Qa-1b–restricted T Cells
somal compartments (58). Given evidence for a TAP-
independent, chloroquine-sensitive endosomal processing
pathway in presentation of insulin by Qa-1b, we evaluated
the antigen presentation activity of spleen cells from invari-
ant chain–deficient mice (Fig. 7 A). Presentation of myo-
globin to control IAb-restricted HMb4.2 T cells was ab-
rogated in the absence of invariant chain. In contrast,
invariant chain expression had no effect on presentation to
6C5 T cells. H-2M catalyzes peptide-exchange reactions in
MHC class II molecules localized in endosomal compartments
(26, 59, 60). The possibility that H-2M can catalyze pep-
tide exchange in class I molecules has not been addressed.
We observed no significant difference in the antigen present-
ing activity of H-2M–deficient and control spleen cells in
experiments with 6C5 T cells (Fig. 7 B). In contrast, con-
trol but not H-2M–negative APCs presented myoglobin to
HMb4.2 T cells. In preliminary in vitro experiments, we
found no evidence that the human homologue of H-2M,
HLA-DM, can catalyze peptide-exchange reactions in pu-
rified MHC class Ia proteins (data not shown). We con-
clude that invariant chain and H-2M are not required for
presentation of insulin to Qa-1b–restricted T cells.
The cytosolic and noncytosolic exogenous class I antigen
processing pathways are selectively localized in macro-
phages (46–48) and dendritic cells (49–51). MHC class II–
negative cells, T cells, and B cells in general are unable to
present exogenous protein determinants to class I–restricted
T cells (47, 52). Exceptions have been reported, but they
appear to be associated with specialized forms of antigen or
specialized mechanisms of antigen uptake (61–63). We
found that a variety of nonphagocytic cell lines present in-
sulin to Qa-1b–restricted T cells, with an efficiency similar
to macrophages or spleen cells (Fig. 8). Antigen presenta-
tion activity correlated with Qa-1b expression as measured
by flow cytometry. 6C5 T cells do not express cell-surface
Figure 6. TAP-independent, chloroquine-sensitive presentation of in-
sulin to Qa-1b–restricted T cells. (A) 6C5 T cells (105/well) were cultured
with various concentrations of antigen in the presence of peritoneal mac-
rophages from TAP2/2 or TAP1/1 B6 mice and 108 1 mm latex beads to
stimulate phagocytosis. (B) B10 spleen cells were preincubated with no
inhibitor, 15 mg/ml chloroquine, 5 mg/ml BFA, or 200 mg/ml leupeptin
for 1 h at 378C. After addition of pork insulin (38 mM), the cultures were
continued for 4 h and the cells were fixed with paraformaldehyde. Vari-
ous numbers of treated spleen cells were cultured with 6C5 T cells (5 3
104), and lymphokine production was measured as described in Materials
and Methods.
Figure 7. Invariant chain and H-2M are not required for presentation
of insulin to Qa-1b–restricted T cells. (A) HMb4.2 and 6C5 T cells (5 3
104/well) were incubated with various concentrations of antigen and 5 3
105 spleen cells from Ii2/2 or Ii1/1 B6 mice. (B) T cells (5 3 104/well)
were incubated with various concentrations of antigen and 5 3 105 spleen
cells from H-2M2/2 or H-2M1/1 B6 mice. Lymphokine production was
measured as described in Materials and Methods.
Figure 8. The antigen processing path-
way for presentation of insulin by Qa-1b is
active in a variety of cell lines. 6C5 T cells
(105/well) were incubated with the indi-
cated cell lines (105/well) or spleen cells
(106/well) in the presence or absence of 20
mM beef insulin (BINS). Lymphokine pro-
duction was measured as described in Mate-
rials and Methods. The APCs were analyzed
for cell surface Qa-1b expression by flow cy-
tometry using Qa-1–specific IgG (solid lines)
or control rabbit IgG (broken lines).967 Tompkins et al.
Qa-1b (data not shown), explaining their inability to re-
spond to insulin in the absence of APCs.
The previously characterized exogenous class I antigen
processing pathways are strongly stimulated by phagocyto-
sis (38, 57, 64). H-2Kb–restricted B3Z T cells respond
weakly to OVA presented by peritoneal macrophages (Fig.
9). This response is markedly enhanced in the presence of
4.5-mm particles as described previously (38). By contrast,
macrophages efficiently present insulin to Qa-1b–restricted
T cells in the absence of phagocytic stimuli, and the re-
sponse is only slightly enhanced in the presence of 4.5-mm
particles (Fig. 9). Thus, it appears that Qa-1b has access to a
novel antigen processing pathway that is constitutively ac-
tive in a wide range of cell types and is not stimulated by
phagocytosis.
Discussion
We describe the isolation and initial characterization of
TCR a/b T cell hybridomas from H-2b mice that recog-
nize pork insulin presented by the nonclassical class I pro-
tein, Qa-1b. The restriction element was localized in ex-
periments with T region congenic mice and identified
using transfected cell lines expressing Qa-1b. Blocking ex-
periments with polyclonal rabbit antisera confirmed that
the T cells directly recognize Qa-1b (data not shown). Ex-
periments with insulin-derived peptides demonstrated that
the determinant recognized by these cells is localized to the
B chain of insulin. The antigen processing pathway used to
present insulin to Qa-1b–restricted T cells is inhibited by
chloroquine and does not require TAP. In contrast to pre-
viously characterized pathways for presentation of exoge-
nous antigens to class I–restricted T cells, this pathway is
constitutively active in a wide variety of cell types and it is
not stimulated by phagocytosis.
The dominant peptide, Qdm, recognized by Qa-1b–
restricted TCR a/b alloreactive T cells is derived from the
leader sequence of D or L MHC class Ia proteins (18). The
natural form of this peptide isolated by acid extraction of
Con A–activated lymphoblasts is a nonamer, and it is the
major peptide associated with Qa-1b in these cells (18, 19).
Similar results were obtained from analysis of peptides
eluted from purified chimeric class I molecules expressing
the a1 and a2 domains of Qa-1b and the a3 domain of Db
expressed in L cell transfectants (20). The limited heteroge-
neity of Qa-1b–associated peptides may reflect a relative
shortage of peptides in the ER with the appropriate se-
quence motif, or it could result from unknown constraints
on the mechanism of peptide loading by Qa-1 molecules.
However, the dominance of Qdm is consistent with the
idea that Qa-1b preferentially binds nonameric peptides
similar to MHC class Ia proteins. Therefore, it is surprising
that we were unable to identify short peptides from the in-
sulin B chain that could stimulate our Qa-1b–restricted T
cells. It is clear that the COOH terminus of the B chain is
essential for T cell activation. Desoctapeptide insulin and
B(1-22), missing the eight COOH-terminal residues of the
B chain, have no activity. However, the NH2 terminus of
the B chain also appears to have residues required for T cell
activation. B(6-30) and shorter NH2-terminally truncated
B chain peptides do not stimulate the Qa-1b–restricted T
cells. It remains possible that the B chain is further pro-
cessed in APCs, and that a covalently modified peptide rep-
resents the final species that associates with Qa-1b.
The possibility that Qa-1b may be especially suited to
bind and present peptides of unusual length cannot be ex-
cluded. Peptide binding assays with Qa-1b–expressing cells
have been used to identify anchor residues in the Qdm se-
quence (20, 44); however, the capacity of longer peptides
to bind Qa-1b has not been directly examined. Aldrich et al.
(18) reported that 8-, 10-, and 11-mer variants differing
from Qdm at the COOH terminus stimulate alloreactive
CTLs with only slightly reduced potency, whereas 7- and
12-mer peptides are 50–100-fold less potent but still dem-
onstrate substantial activity in cytotoxicity assays. Longer
peptides were not tested. Imani and Soloski (22) demon-
strated that a tryptic digest of M. bovis 65-kD heat shock
protein, containing peptides of various lengths, stabilizes
cell surface Qa-1b molecules. The determinant(s) recog-
nized by recently described Qa-1b–restricted, L. monocy-
togenes–specific CTLs has yet to be defined (24). Qa-1b
(and Qa-1a) differ from other class I molecules by serines at
positions 143 and 147 instead of threonine and tryptophan,
respectively (15, 16, 65). These positions represent two of
four highly conserved residues in the F pocket that form
hydrogen bonds with the COOH terminus of class I–bound
peptides, limiting their length and contributing substan-
tially to the stability of the complexes (66). The conse-
quence of these substitutions on the binding specificity and
stability of Qa-1b–peptide complexes is unknown, but it is
possible that interactions involving the COOH terminus of
bound peptide play a smaller role in Qa-1 than other class I
molecules. Mouse CD1 preferentially binds peptides 14–24
amino acids in length to form complexes that can be recog-
nized specifically by TCR a/b CTLs, providing an exam-
ple of a class I–related molecule that binds long peptides
Figure 9. Phagocytic stimulus enhances the processing and presenta-
tion of OVA but not insulin by peritoneal macrophages. (A) B3Z (OVA-
specific, Kb-restricted) or 6C5 T cells (5 3 104/well) were cultured with
5 3 104 thioglycollate-elicited peritoneal macrophages and 40 mM anti-
gen in the absence or presence of 4.5 mm DynabeadsTM as indicated.
Lymphokine production was measured as described in Materials and
Methods. (B) The data were replotted to indicate the relative enhance-
ment of T cell responses observed in the presence of beads.968 Insulin Recognition by Qa-1b–restricted T Cells
(67). In addition, the three-dimensional structure of a pep-
tide extending out of the COOH-terminal end of the pep-
tide-binding site of a class Ia protein has been reported
(68). The conserved residues that form hydrogen bonds
with the peptide NH2 terminus in class I molecules are
conserved in Qa-1 (15, 16, 65). Thus, if the insulin B chain
extends out of the NH2-terminal end of the peptide-bind-
ing site in Qa-1b, the complex is likely to be very unstable
with a rapid rate of dissociation. This possibility must be
considered because insulin derivatives with a chemically mod-
ified B chain a amino group retain activity in T cell assays.
In addition, antigen-pulsed APCs stimulate substantially lower
T cell responses compared with those observed in the con-
tinuous presence of antigen. This suggests that the relevant
peptide complexes may be short-lived. Vidovic et al. (21)
have described a TCR g/d T cell hybridoma that recognizes
synthetic copolymer poly(Glu50Tyr50) presented by Qa-1b
on the surface of fixed APCs. This polymer has been shown
to stabilize cell surface Qa-1b molecules (22). Soloski et al.
(13) demonstrated that radioiodinated poly(Glu50Tyr50) binds
specifically to Qa-1b on L cell transfectants without size se-
lection, ruling out the possibility that short peptides con-
taminating the polymer preparation are responsible for the
observed activity. Thus, several observations support the
possibility that Qa-1b may be able to bind and present un-
usually long peptide antigens.
The results of experiments with inhibitors and APCs
from TAP knockout mice suggest that a noncytosolic pro-
cessing pathway is used to present insulin to Qa-1b–restricted
T cells. Chloroquine completely inhibited antigen presen-
tation, implicating endosomal compartments in the pro-
cessing pathway. APCs from TAP-deficient animals were
almost as efficient as cells from control mice in antigen pre-
sentation. The slightly reduced activity of TAP-deficient
APCs can be explained by a reduction in the quantity of
Qa-1b–peptide complexes assembled in the ER and com-
petent for export to the cell surface or endosomal compart-
ments. Formation of Qa-1b–Qdm complexes is TAP-
dependent (69). Since this is likely to be the major peptide
complex assembled in the ER (19, 70), one would expect a
reduction in Qa-1 transport in TAP-negative APCs. Bio-
chemical evidence has also been obtained demonstrating
reduced maturation and transport of Qa-1b molecules in
activated T cells from TAP-negative mice (13). However,
a substantial fraction of alloreactive CTLs specific for Qa-1b
recognize TAP-independent determinants (69), and Qa-1b
transport is only partially inhibited in TAP-deficient spleen
cells (13). Thus, a cohort of Qa-1b molecules should still be
available for peptide-exchange reactions in post-ER com-
partments in TAP-deficient cells. This interpretation would
also account for the observation that antigen presentation is
substantially inhibited by BFA, which blocks transport to
post-ER compartments. Qa-1b has a very rapid turnover
rate in cells (15, 22), and thus there may be a substantial re-
duction in the quantity of molecules available for exchange
reactions in post-ER compartments after relatively short
incubations with BFA.
Both cytosolic and noncytosolic pathways have been de-
scribed for the presentation of exogenous protein antigens
to class I–restricted T cells (52, 53). In general, these path-
ways are selectively active in macrophages (46–48) and a
subpopulation of dendritic cells (49–51) but not B cells, T
cells, or other class II–negative cell types. Therefore, it is
striking that a wide variety of MHC class II–positive and
–negative cell lines derived from different tissues are able to
present insulin to Qa-1b–restricted T cells with efficiencies
similar to peritoneal macrophages or unfractionated spleen
cells. Presentation of exogenous proteins by class I mole-
cules in macrophages is markedly enhanced under condi-
tions favoring uptake of antigen by phagocytosis (54, 56,
57, 64) or macropinocytosis (48). Reis e Sousa and Ger-
main (38) demonstrated that antigen does not need to be
physically coupled to particles to stimulate presentation of
OVA to Kb-restricted T cells. This suggests that phagocy-
tosis, by itself, activates the exogenous class I antigen pro-
cessing pathway (38). Results presented here confirm that
4.5-mm particles strongly enhance the processing of soluble
OVA by peritoneal macrophages for presentation to Kb-
restricted T cells. The observation that particles have little
effect on the presentation of insulin by macrophages to Qa-
1b–restricted T cells further distinguishes the exogenous
antigen processing pathway used by Qa-1b from that de-
scribed previously for MHC class Ia molecules.
It is possible that Qa-1b is selectively targeted to endosomal
compartments, where it can participate in peptide-exchange
reactions. The class I–related human CD1b protein is selec-
tively targeted to endosomes through a tyrosine-based target-
ing motif in the cytoplasmic domain (6). A similar motif is
present in the cytoplasmic domain of Qa-1b, and experiments
are in progress to evaluate the requirement for the cyto-
plasmic domain in stimulating insulin-specific T cells. Immu-
nofluorescence analysis clearly demonstrates an endosomal
localization pattern for CD1b (6). In contrast, Qa-1b is pre-
dominantly localized in the ER and at the cell surface in a
pattern similar to class Ia molecules (data not shown). Thus, if
Qa-1b is targeted to endosomes, only a fraction of the mole-
cules reside in these compartments under steady-state con-
ditions. Sugita and Brenner (58) demonstrated that a frac-
tion of human class Ia molecules binds to the Ii in cells
expressing this protein. The class I–invariant chain com-
plexes were shown to be transported to endosomal com-
partments. We addressed the possibility that invariant chain
may be required for targeting Qa-1b to endosomes. How-
ever, splenic APCs from invariant chain–deficient mice
were found to have no reduction in antigen presentation
activity. It is possible that the intracellular trafficking pat-
tern of Qa-1b is similar to that of class Ia proteins, but that
intrinsic features of the molecule make it particularly well
suited to participate in peptide-exchange reactions. As
noted above, Qa-1b has a high turnover rate in cells (15,
22), which could result from rapid peptide dissociation and
consequent denaturation of empty molecules. Kurepa and
Forman (44) have reported that Qa-1b–Qdm complexes
are relatively stable, with a t1/2 of z10 h at 48C. However,969 Tompkins et al.
it is likely that these complexes are substantially less stable at
378C. Given the assumption that Qa-1b–Qdm complexes
represent the most stable Qa-1b–peptide complexes, it is
likely that peptide-receptive Qa-1b molecules are generated
rapidly under physiological conditions.
The function of insulin-specific, Qa-1b–restricted T cells
remains to be determined. H-2b mice are nonresponders to
pork insulin, generating little if any antibody after immuni-
zation with this antigen (71). Beef insulin, differing from
pork insulin by only two amino acids in the A chain, stim-
ulates high-titered antibody responses in H-2b mice. Weak
secondary in vitro proliferation responses can be measured
after immunization with pork insulin, demonstrating that
pork insulin–reactive T cells can be induced in these ani-
mals. T cell hybridomas generated from pork insulin–
primed B6 or B10 mice generated in our laboratory fall
into two groups: CD41, TCR a/b-expressing cells that
recognize B(17-30) presented by IAb, and TCR a/b cells
that recognize B chain presented by Qa-1b. The Qa-1b–
restricted T cell hybridomas express CD8 only if a CD81
fusion partner is used in their generation. Loss of CD8 ex-
pression is commonly observed after fusion of CD81 T
cells to BW5147 (72). Although it is likely that the Qa-
1b–restricted T cells express CD8 in vivo, we cannot rule
out the possibility the hybridomas are derived from a
CD42CD82 population. Anti-CD8 mAbs block antigen-
induced stimulation of the CD81 hybridomas (data not
shown). However, the observation that some hybridomas
can recognize insulin presented by Qa-1b in the absence of
CD8 suggests that the repertoire contains high-avidity
TCRs with this specificity. A preliminary analysis of five
independent hybridomas suggests that TCR Vb use is not
restricted (data not shown). It is interesting to consider the
possibility that the Qa-1b–restricted T cells may somehow
be involved in regulating the immune response to insulin
in nonresponder mice. The poly(Glu50Tyr50)-specific TCR
g/d T cells reported by Vidovic et al. (21) were generated in
nonresponder mice (73). In addition, Jiang et al. (23) have
described TCR a/b CTLs responsible for the peripheral
deletion of CD41 T cells that is observed after injection of
SEB. These CTLs apparently recognize TCR Vb determi-
nants presented by Qa-1 (23). Thus, Qa-1 could have a spe-
cial role in mediating regulatory interactions between T cells.
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